Jill Wechsler is BioPharm International's Washington editor.
Demand for new therapies and vaccines spotlights production challenges.
FDA demands accurate manufacturing and test information to ensure product quality.
Attendees at the Bio-Process Systems Alliance annual summit discuss the benefits of single-use technology in biopharmaceutical manufacturing.
FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.
Supplier Audit Program Marks Progress
Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.
Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.
New formulations and expanded vaccine production are encouraged.
New identifiers and tracking requirements aim to block illegitimate products.